HeiQ Chrisal water treatment solution contract win
This article is not intended to be distributed in the USA.
9 June 2021
HeiQ Plc
("HeiQ" or "the Company")
HeiQ Chrisal sustainable water treatment solution contract win
HeiQ Plc (LSE:HEIQ), an established global brand in materials and textile innovation which operates in high-growth markets, is pleased to announce that its subsidiary, HeiQ Chrisal, which focuses on delivering industrial biotechnology solutions by incorporating the benefits of probiotics and synbiotics , has signed a partnership with Wöllner GmbH, one of Europe's leading suppliers of soluble silicates, process chemicals and specialty additives for industrial applications.
Under the terms of the distribution agreement, which will deliver revenues of at least €2 million to HeiQ Chrisal over a five-year period, Wöllner will offer its +150 customers an environmentally friendly, non-biocidal microbial management and cleaning solution developed by HeiQ Chrisal. The solution will be added to Wöllner's Process Enhancement Chemicals (PEC) product lines for industrial water circuits and Wöllner will have exclusivity over Germany, Austria, Switzerland, Finland, Denmark, Norway and Sweden in the defined field. Wöllner has selected HeiQ Chrisal's solution due to its ability to deliver superior efficiency, hygiene and sustainability benefits in comparison to alternative, chemical-based solutions.
Carlo Centonze, Co-founder & CEO of HeiQ Group, said: "This agreement is of strategic importance for HeiQ Chrisal, providing this innovative business access to the previously unentered arena of industrial water circuits. Wöllner continually focuses on providing its clients with high-quality and eco-friendly products for its customers and therefore, we are delighted that the team has recognized the superior results that environmentally friendly probiotics solutions can deliver. We believe that this is just the start of similar contracts which have the potential to deliver solid growth to HeiQ as we strengthen our presence in the $50 billion probiotics market."
Dr. Barbara März, CEO of Wöllner, said: "Innovation is the only answer to a more sustainable world and HeiQ Chrisal is at the very forefront of it. We are excited to partner with HeiQ Chrisal in delivering this innovative and environmentally friendly solution to our customers in industrial water circuits. We welcome all our customers to consult us for the planning and installation of dosing systems using such innovative and more environmentally friendly probiotic process enhancement technology."
For further information, please contact:
|
HeiQ Plc Carlo Centonze (CEO) |
+41 56 250 68 50 |
|
Arlington Group Asset Management Limited (Financial Advisor and Joint Broker) Charles Cannon Brookes |
+44 (0) 207 389 5017 |
|
Cenkos Securities plc (Joint Broker) Stephen Keys / Callum Davidson |
+44 (0) 207 397 8900 |
|
SEC Newgate (Media Enquiries) Elisabeth Cowell / Robin Tozer / Megan Kovach |
+44 (0) 20 3757 6882 |
About HeiQ
HeiQ is focused on improving the lives of billions of people world-wide by innovating the materials people use every day. It is an IP-rich pioneer which is at the forefront of global technology in the $10 billion antimicrobial fabrics and $24 billion textile chemicals market. It has also moved into the medical device, healthcare and probiotics markets, to help make hospitals and healthcare environments more hygienic.
HeiQ has created some of the most effective, durable and high-performance technologies and textile effects in the market today, which cool, warm, dry, repel, purify, and destroy viruses. Since 2005, HeiQ has developed over 200 technologies in partnership with 300 major brands. It has won multiple awards and gained a strong reputation for sustainability.
Led by an experienced management team, HeiQ rapidly researches new solutions for partners, quickly delivers scaled up manufacturing from its sites across the world and helps partners market the product to end consumers - aiming for lab to consumer in months.
HeiQ aims to deliver growth for its shareholders through a combination of increased sales of its core products and by entering additional lucrative markets through disruptive innovations and M&A. It has a healthy R&D pipeline containing over 40 projects.
About Wöllner
Wöllner is one of Europe's leading suppliers of soluble silicates, process chemicals and specialty additives for industrial applications.
Wöllner has in-depth expertise in applied chemistry, covering the areas of research, development and production and continually invests in the development of high-quality and eco-friendly products and application systems.
Wöllner is a family-run enterprise with 125 years of experience, founded by Eduard Wöllner in 1896 in Ludwigshafen. It has three production sites in Germany and Austria and 150 professionals, including production, research & development, analytical & microbiological lab.
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 16 minutes ago Savills
- 36 minutes ago Everyman Media Group
- 1 hour ago Croda International
- 2 hours ago Diageo
- 2 hours ago IMI